Sanofi adds diabetes to collaborative effort at UCSF

Sanofi ($SNY) is broadening its research ties with the University of California in San Francisco, which has been steadily growing its collaborative work with the biopharma industry under Chancellor Susan Desmond-Hellmann. In the new $3.1 million pact, Sanofi researchers will work with investigators on new treatments for diabetes. Scientists are already joining forces with Sanofi on brain trauma and oncology. Release

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.